Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 123 | 998 | 25,364 | -73,811 | 40,134 |
| Cost of Goods | -75 | 140 | 21,343 | -9,480 | 4,243 |
| Gross Profit | 198 | 858 | 4,021 | -64,331 | 35,891 |
| Operating Expenses | 47,815 | 47,406 | 53,546 | 30,289 | 99,616 |
| Operating Income | -47,692 | -46,408 | -49,182 | -95,100 | -63,482 |
| Interest Expense | 2,069 | 1,868 | 2,092 | -2,368 | 5,022 |
| Other Income | 1,472 | 900 | 2,235 | -390 | 4,296 |
| Pre-tax Income | -48,289 | -47,376 | -49,039 | -93,122 | -64,208 |
| Income Tax | 3 | -281 | 7 | -175 | 84 |
| Net Income Continuous | -48,292 | -47,095 | -49,046 | -94,970 | -63,615 |
| Net Income Discontinuous | 31,208 | 31,551 | 16,113 | N/A | N/A |
| Net Income | $-17,084 | $-15,544 | $-32,933 | $-56,232 | $-63,615 |
| EPS Basic Total Ops | -4.25 | -3.89 | -8.25 | -14.00 | -16.25 |
| EPS Basic Continuous Ops | -12.01 | -11.79 | -12.25 | -24.13 | -16.19 |
| EPS Basic Discontinuous Ops | 7.76 | 7.90 | 4.00 | N/A | N/A |
| EPS Diluted Total Ops | -4.25 | -3.89 | -8.25 | -14.00 | -16.25 |
| EPS Diluted Continuous Ops | -12.01 | -11.79 | -12.25 | -24.13 | -16.19 |
| EPS Diluted Discontinuous Ops | 7.76 | 7.90 | 4.00 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -4.25 | -4.00 | -8.25 | -14.25 | N/A |
| EBITDA(a) | $-46,952 | $-46,014 | $-49,656 | $-94,632 | $-62,943 |